Systemic oxygenation weakens the hypoxia and hypoxia inducible factor 1α-dependent and extracellular adenosine-mediated tumor protection

  • Stephen M. Hatfield
  • , Jorgen Kjaergaard
  • , Dmitriy Lukashev
  • , Bryan Belikoff
  • , Taylor H. Schreiber
  • , Shalini Sethumadhavan
  • , Robert Abbott
  • , Phaethon Philbrook
  • , Molly Thayer
  • , Dai Shujia
  • , Scott Rodig
  • , Jeffrey L. Kutok
  • , Jin Ren
  • , Akio Ohta
  • , Eckhard R. Podack
  • , Barry Karger
  • , Edwin K. Jackson
  • , Michail Sitkovsky

Research output: Contribution to journalArticlepeer-review

181 Scopus citations

Abstract

Intratumoral hypoxia and hypoxia inducible factor-1α (HIF-1-α)-dependent CD39/CD73 ectoenzymes may govern the accumulation of tumor-protecting extracellular adenosine and signaling through A2A adenosine receptors (A2AR) in tumor microenvironments (TME). Here, we explored the conceptually novel motivation to use supplemental oxygen as a treatment to inhibit the hypoxia/HIF-1α-CD39/CD73-driven accumulation of extracellular adenosine in the TME in order to weaken the tumor protection. We report that hyperoxic breathing (60 % O2) decreased the TME hypoxia, as well as levels of HIF-1α and downstream target proteins of HIF-1α in the TME according to proteomic studies in mice. Importantly, oxygenation also downregulated the expression of adenosine-generating ectoenzymes and significantly lowered levels of tumor-protecting extracellular adenosine in the TME. Using supplemental oxygen as a tool in studies of the TME, we also identified FHL-1 as a potentially useful marker for the conversion of hypoxic into normoxic TME. Hyperoxic breathing resulted in the upregulation of antigen-presenting MHC class I molecules on tumor cells and in the better recognition and increased susceptibility to killing by tumor-reactive cytotoxic T cells. Therapeutic breathing of 60 % oxygen resulted in the significant inhibition of growth of established B16.F10 melanoma tumors and prolonged survival of mice. Taken together, the data presented here provide proof-of principle for the therapeutic potential of systemic oxygenation to convert the hypoxic, adenosine-rich and tumor-protecting TME into a normoxic and extracellular adenosine-poor TME that, in turn, may facilitate tumor regression. We propose to explore the combination of supplemental oxygen with existing immunotherapies of cancer.

Key messages: Oxygenation decreases levels of tumor protecting hypoxia. Oxygenation decreases levels of tumor protecting extracellular adenosine. Oxygenation decreases expression of HIF-1alpha dependent tumor-protecting proteins. Oxygenation increases MHC class I expression and enables tumor regression.

Original languageEnglish (US)
Pages (from-to)1283-1292
Number of pages10
JournalJournal of Molecular Medicine
Volume92
Issue number12
DOIs
StatePublished - Nov 29 2014
Externally publishedYes

Keywords

  • Adenosine
  • CD73
  • Cancer
  • HIF-1α
  • Hypoxia
  • Immunology

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery
  • Genetics(clinical)

Fingerprint

Dive into the research topics of 'Systemic oxygenation weakens the hypoxia and hypoxia inducible factor 1α-dependent and extracellular adenosine-mediated tumor protection'. Together they form a unique fingerprint.

Cite this